Bioclanic 500 mg + 125 mg flavoured tablets for dogs
Bioclanic 500 mg + 125 mg flavoured tablets for dogs
Authorised
- Amoxicillin trihydrate
- POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
Product identification
Medicine name:
Bioclanic 500 mg + 125 mg flavoured tablets for dogs
Bioclanic 500 mg + 125 mg Tabletka
Active substance:
- Amoxicillin trihydrate
- POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Amoxicillin trihydrate573.95/milligram(s)1.00Tablet
-
POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)297.81/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Package description:
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: Cardboard box of 10 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: Cardboard box of 20 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: Cardboard box of 30 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: Cardboard box of 40 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: Cardboard box of 50 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: Cardboard box of 100 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: Cardboard box of 150 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: Cardboard box of 200 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: Cardboard box of 250 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Duggan Veterinary Supplies Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 3363
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0788/003
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Greece
-
Hungary
-
Italy
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 28/09/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 6/05/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 6/05/2025
ie-puar-mr-iev0788003-bioclanic-500-mg--125-mg-flavoured-tablets-for-dog-en.pdf
English (PDF)
Download Published on: 28/09/2025
How useful was this page?: